加强外部对冲脉动 (EECP) 作为高血压的替代治疗方法的评估:系统性审查和元分析
Ratnadeep Biswas1, HariOm Vaja2, Vishnu Shankar Ojha1
1From the Department of Medicine, All India Institute of Medical Sciences, Patna, Bihar India.
Cardiology in review
|May 1, 2025
概括
增强的外部反推力 (EECP) 在高血压患者中显著降低了静缩和静缩血压. 这种非侵入性治疗显示出作为有效的辅助治疗高血压管理的承诺.
科学领域:
- 心血管医学 心血管医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内部医学 内部医学
背景情况:
- 高血压是一个普遍存在的全球健康问题,需要有效的管理策略.
- 增强外部反推力 (EECP) 是一种具有潜在心血管益处的非侵入性疗法.
- 在高血压患者中降低血压的EECP的有效性需要系统评估.
研究的目的:
- 系统地审查和分析EECP降低高血压患者血压的有效性.
- 评估EECP对静缩血压 (SBP) 和静缩血压 (DBP) 的影响.
主要方法:
- 进行了系统审查和元分析,最初选了323篇文章.
- 涉及1504名患者的37项研究符合纳入标准;其中11项被纳入了元分析.
- EECP治疗的持续时间各不相同,大多数患者接受约35小时的治疗.
主要成果:
- 后分析表明,SBP显著减少 (平均差异: -7.85 mm Hg,P < 0.00001).
- 还观察到DBP的显著下降 (平均差异: -3.94 mm Hg,P < 0.00001).
- 平均动脉压没有显著变化 (P = 0.17),出版偏差最小.
结论:
- 在高血压患者中,EECP治疗显著降低了SBP和DBP.
- 在高血压管理方面,EECP是一个有前途的非侵入性,辅助性治疗选择.
- 需要进一步的研究来阐明机制和长期益处,使用标准化的协议.
相关概念视频
01:28Special considerations while measuring blood pressure
When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:17Measurement of Blood Pressure
Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a stethoscope.
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...